Rentschler Biopharma, a CDMO for biopharmaceuticals, today has hired Grace Kim as VP of Business Development for North America and APAC. This is a newly created, US-based position.
Federico Pollano, Senior VP of Business Development, said: “We are delighted to have Grace join Rentschler Biopharma. She is a talented leader with proven experience in successfully growing global CDMO businesses who shares our client-centric approach. We, at Rentschler Biopharma, believe that collaborating closely with our strategic partners – our clients – is essential to the successful bioprocess development and production of high-quality complex biopharmaceuticals. Grace will play a key role in expanding our offering of best-in-class services for cell culture projects as well as for new therapeutic modalities. We warmly welcome Grace to our growing US-based team.”
Kim is an accomplished business development executive with over 20 years of broad-based experience in the biopharmaceutical industry. She has a proven track record of driving significant growth in revenue through successful execution of long-term partnerships. Kim has held several global business development positions at companies specializing in process development and cGMP production of recombinant protein therapeutics in both microbial and mammalian expression systems. Most recently, she was VP at Northway Biotechpharma. Before that, she held a senior leadership position with the global contract manufacturing organisation, Samsung Biologics.
Grace has a BA from Hamilton College and an MS from The Johns Hopkins University.
Kim said: “Rentschler Biopharma has a reputation for high quality, dependability and innovation, and I am excited to join the team as it expands its international footprint to the US as well as Asia Pacific. I look forward to bringing in new strategic partnerships to maximise the utilisation of the Milford site as well as to expand the global business development team, commensurate with growth in business.”
